Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

RXRXRXRX
Showing 8 of 21 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in RECURSION PHARMACEUTICALS IN

GEODE CAPITAL MANAGEMENT, LLC holds 13.8M shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $50.7M as of 2026-Q2. The position was increased (+12.6% shares). RXRX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$50.7M

Current Shares

13.8M

Total Value Change

+$14.9M

Total Shares Change

+8.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
13.8M
+12.6%
$50.7M0.0%$3.67
33
2026-Q1
Increased
12.3M
+12.3%
$37.7M0.0%$3.54
33
2025-Q4
Increased
10.9M
+13.6%
$44.7M0.0%$4.11
33
2025-Q3
Increased
9.6M
+23.8%
$47M0.0%$4.91
36
2025-Q2
Increased
7.8M
+20.7%
$39.4M0.0%$5.03
35
2025-Q1
Increased
6.4M
+5.9%
$34.1M0.0%$5.81
31
2024-Q4
Increased
6.1M
+12.1%
$41.2M0.0%$6.77
33
2024-Q3
Increased
5.4M
+13.7%
$35.8M0.0%$6.98
33

Other major holders of RXRX: BAILLIE GIFFORD & CO, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used